Project
‹ Go back to overview

A3267 Fleming Fund Evaluation

Financer:
DFID
Country:
Global, Tanzania, Vietnam
Field of Expertise:
Health Service Delivery; Communicable diseases (CD); Infectious diseases / epidemic / outbreak / vaccination; Health Research and Information; Health Research; Research Programme Evaluations
Narrative description of project:
The Fleming Fund was announced in 2015 as a £265 million commitment to support low- and middle-income countries tackling antimicrobial resistance (AMR). The fund is provided by the UK’s Official Development Assistance (ODA) budget and is managed by the Department of Health and Social Care (DHSC). The Fleming Fund invests in a range of projects targeted at improving AMR data and surveillance through a group of diverse delivery partners.

hera conducted an evaluation of the fund covering two phases:

• Inception phase 2016 - 2018
• Primary activities with grants to WHO, FAO and OIE as well as set up of other smaller grants with academic and civil society organisations.
• Procurement and management of an inception phase with the Country/Regional Grant & Fellowship Management Agent and Independent Evaluation Supplier.
• Implementation phase 2018 – 2019 and onwards
• Continued activities with grants to WHO, FAO and OIE as well as running of other smaller grants with academics and civil society organisations.
• Implementation phase with Country/Regional Grant & Fellowship Management Agent and Independent Evaluation Supplier.
• Development of a portfolio of complementary grants with new organisations to expand into other key objectives for the Fleming Fund including optimising the use of antimicrobial medicines, developing the business case for AMR and providing technical advisory support on One Health activities.
Description of services provided:
hera reviewed two key documents, provided consultation services and conducted key interviews. Two evaluation reports were provided to the Global Health Security Programme Board and to the Fleming Fund Technical Advisory Group.